It was confirmed by the analysis in Annexin V binding assay, as well as our observation of the increased caspase-8 and caspase-9 concentrations and decreased mitochondrial membrane potential in comparison with the untreated control in both MCF-7 and MDA-MB-231 breast cancer cells. The gene discussed is ANXA5; the disease is breast carcinoma.